BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Laser capture microdissection
,
Tamoxifen
,
rs2300478
,
DRD2
,
calcium channel activity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
plasma catecholamine
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
Pro-B BA/F3 cells treated with endocannabinoid N-arachidonoyl dopamine (NADA)
Explore Curated Studies Results
Literature
Most Relevant Literature
Synuclein modulation of monoamine transporters.
Effect of cimetidine on pentamidine induced hyperglycemia in rats.
A catecholamine transporter from the human parasite Schistosoma mansoni with low affinity for psycho…
Renal tumours in a Tsc1+/- mouse model show epigenetic suppression of organic cation transporters Sl…
Time-course activities of Oct1, Mrp3, and cytochrome P450s in cultures of cryopreserved rat hepatocy…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Evaluation of Plasma Catecholamine Concentration During Surgery
Catecholamine Response to Repeated Whole-Body Cryostimulation in Obesity
Catecholamines Can Attenuate Intermittent Hypoxia-Induced Expression of TNF in Human Monocytes
Epigallocatechin Gallate Lowers Circulating Catecholamine Concentrations and Alters Lipid Metabolism…
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ